Analyst Ratings for Vir Biotechnology (VIR)

VIR Rating Summary

VIR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on VIR
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $66.71 (+55.3%) * Over Last 12-Mos
Rating Score: 8.6 / 10   Percentile Rank: 87%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/27/2021 JPMorgan Anupam Rama Downgrade Underweight
(Neutral)
30.00
(28.00)
44.39
(42.97)
-3.2% Details
10/5/2020 BofA Securities N/A New Coverage Buy
(N/A)
55.00
(N/A)
33.33
(42.97)
28.92% Details
Like VIR Ratings? Also take a look at GSK, LLY, BIIB, VBIV

VIR Ratings News